 |
 |

Outpatient Treatment of Child and Adolescent Depression in the United States
Mark Olfson, MD, MPH;
Marc J. Gameroff, PhD;
Steven C. Marcus, PhD;
Bruce D. Waslick, MD
Arch Gen Psychiatry. 2003;60:1236-1242.
Background Although psychotherapy has traditionally been the dominant form of treatment for children and adolescents with depression, there has been a recent increase in the prescription of antidepressants for this age group.
Objective To describe patterns of outpatient treatment for children and adolescents with depression.
Design and Setting Analysis of health serviceuse data from 4 consecutive years (1996-1999) of the Medical Expenditure Panel Survey, a nationally representative annual survey of the general population that is sponsored by the Agency for Healthcare Quality and Research, Rockville, Md.
Subjects Patients aged 6 to 18 years who made 1 or more outpatient visits for the treatment of depression.
Main Outcome Measures Rate of treatment, mental health problems, psychotropic medication use, psychotherapy use, number of outpatient treatment visits, and type of provider.
Results Across the 4 survey years, the mean annual rate of outpatient treatment for depression was 0.93 per 100 individuals. The rate of treatment was especially low for African American individuals (0.23 per 100) and uninsured individuals (0.43 per 100). Approximately three quarters (79%) of treated children and adolescents received psychotherapy and more than half (56.9%) were prescribed antidepressant medications. The mean number of treatment visits for depression was 7.8 per year. As compared with children and adolescents with depression who were treated without antidepressants, those who received antidepressants were significantly more likely to have evidence of anhedonia, to live in large urban communities, to have parents who graduated from high school, and to have health insurance.
Conclusions The rate and pattern of treatment suggest that serious gaps exist in access to community outpatient treatment for children and adolescents with depression. At the same time, antidepressant medications are used far more commonly than would be expected on the basis of published treatment recommendations.
From the New York State Psychiatric Institute and the Department of Psychiatry, College of Physicians and Surgeons, Columbia University, New York (Drs Olfson, Gameroff, and Waslick); and the School of Social Work, University of Pennsylvania, Philadelphia (Dr Marcus).
CiteULike Connotea Del.icio.us Digg Reddit Technorati
What's this?
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
 |
Screening for Child and Adolescent Depression in Primary Care Settings: A Systematic Evidence Review for the US Preventive Services Task Force
Williams et al.
Pediatrics 2009;123:e716-e735.
ABSTRACT
| FULL TEXT
Pharmacologic Treatment of Posttraumatic Stress Disorder Among Privately Insured Americans
Harpaz-Rotem et al.
Psychiatr. Serv. 2008;59:1184-1190.
ABSTRACT
| FULL TEXT
Effect of Regulatory Warnings on Antidepressant Prescribing for Children and Adolescents
Kurian et al.
Arch Pediatr Adolesc Med 2007;161:690-696.
ABSTRACT
| FULL TEXT
Recognizing and treating depression in children and adolescents
Dopheide
Am J Health Syst Pharm 2006;63:233-243.
ABSTRACT
| FULL TEXT
Pediatric Behavioral Health in Primary Care: A Collaborative Approach
Campo et al.
J Am Psychiatr Nurses Assoc 2005;11:276-282.
ABSTRACT
Fragmented Care for Inner-City Minority Children With Attention-Deficit/Hyperactivity Disorder
Guevara et al.
Pediatrics 2005;116:e512-e517.
ABSTRACT
| FULL TEXT
Pharmacologic Response to Depressive Disorders Among Adolescents
Sewitch et al.
Psychiatr. Serv. 2005;56:1089-1097.
ABSTRACT
| FULL TEXT
Adult Ambulatory Care Visits to Nurses and Physicians: Methodological Limitations of the Medical Expenditure Panel Survey Data
Rosenfeld et al.
Policy Politics Nursing Practice 2005;6:221-228.
ABSTRACT
Antidepressants, Suicide, and the FDA: A Loose Association
Finley
The Annals of Pharmacotherapy 2004;38:1739-1742.
FULL TEXT
Antidepressant Medications in Children
Vitiello and Swedo
NEJM 2004;350:1489-1491.
FULL TEXT
|